Patent · US Active

Hepatitis C virus inhibitors

US8691757B2 · kind B2 · utility

0Cited by

13References

18Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Ramkumar Rajamani · Wallingford, US
Kishore V. Renduchintala · Hyderabad, IN
Kandhasamy Sarkunam · Hosur, IN
Pulicharla Nagalakshmi · Bengaluru, IN
Nicholas A. Meanwell · East Hampton, US
Paul Michael Scola · Glastonbury, US

Key dates

Filing date	Jun 11, 2012
Grant date	Apr 8, 2014
Priority date	—
Expiry date	Sep 25, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/0804
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Hepatitis C virus inhibitors having the general formula (I)are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.